The federal health insurance institute of the Federation of Bosnia and Herzegovina. Day-to-day insurance in the Federation is run by ten cantonal funds; this institute holds the Solidarity Fund, which pays for cancer medicines on its list and for the most complex treatment, so patients in every canton have the same entitlement.
The Institute was founded under the Federation's Law on Health Insurance and began work by Government decision of 14 May 1998. Its governing board has 11 members, one from each canton and one from the Federal Ministry of Health. Its address is Trg Heroja 14, Sarajevo; the coordinates are approximate.
The Solidarity Fund, set up under article 13 of the same law, has operated since 1 July 2002. The Institute says it exists so that the most serious illnesses are treated on the same terms for every insured person in the Federation, whatever their canton and whatever the finances of the cantonal insurance fund. It is financed from compulsory health insurance contributions and partly from the Federation's budget. It pays for the services on its list, the medicines on its medicines list, and treatment abroad under a rulebook.
Cancer medicines are the first group on the list. The decision on the list adopted by the Government of the Federation on 27 June 2019 (Official Gazette of the Federation 47/19, amended in 2019, 2023 and 2024) has a section of cytostatics and a section of cytostatics with a special prescribing regime, which include trastuzumab and pertuzumab for HER2-positive breast cancer, nivolumab for advanced melanoma, and pembrolizumab for non-small cell lung cancer with PD-L1 expression of 50% or more. Expert committees approve the special-regime medicines: one for breast and lung cancer, one for other cancers, one for metastatic melanoma, a haematology committee, and a committee for children's cancers treated abroad. The Institute also publishes running lists of medicines whose supply has been temporarily or permanently interrupted.
Shares Clinical Centre University of Sarajevo (KCUS), Institute for Public Health of the Federation of Bosnia and Herzegovina.
Shares Clinical Centre University of Sarajevo (KCUS), Breast cancer (all types).
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/